According to Novanta's latest financial reports the company's current revenue (TTM) is $0.88 B. In 2022 the company made a revenue of $0.86 B an increase over the years 2021 revenue that were of $0.70 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.88 B | 2.41% |
2022 | $0.86 B | 21.8% |
2021 | $0.70 B | 19.67% |
2020 | $0.59 B | -5.67% |
2019 | $0.62 B | 1.91% |
2018 | $0.61 B | 17.85% |
2017 | $0.52 B | 35.49% |
2016 | $0.38 B | 2.99% |
2015 | $0.37 B | 2.44% |
2014 | $0.36 B | 13.12% |
2013 | $0.32 B | 18.75% |
2012 | $0.27 B | -18.46% |
2011 | $0.33 B | -13.18% |
2010 | $0.38 B | 50.76% |
2009 | $0.25 B | -11.81% |
2008 | $0.28 B | -9.27% |
2007 | $0.31 B | 1.38% |
2006 | $0.31 B | 20.26% |
2005 | $0.26 B | -20.98% |
2004 | $0.33 B | 77.85% |
2003 | $0.18 B | 16.65% |
2002 | $0.15 B | -35.83% |
2001 | $0.24 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | $2.45 M | -99.72% | ๐บ๐ธ USA |
Philips PHG | $19.72 B | 2,136.93% | ๐ณ๐ฑ Netherlands |